Hypertension (high blood pressure) decisions — 2025

The Board denied service connection for hypertension and residuals of a stroke, finding no evidence linking these conditions to the Veteran's active service. The claims for acne, erectile dysfunction, and sinusitis were remanded for further development.

The Board granted service connection for hypertension and migraine headaches, finding that both conditions had their onset during active military service or were due to a service-connected disability.

The Veteran is granted an allowance for an automobile or other conveyance due to his service-connected coronary artery disease causing strokes that have resulted in effective loss of the use of his extremities.

The Board granted service connection for a heart disability and denied service connection for diabetes mellitus, type II (DM II). The claims for chronic kidney disease and hypertension were remanded.

The Board denied the veteran's claims for service connection and an earlier effective date, as well as a compensable rating for hearing loss.

The Board denied service connection for hypertension as the evidence did not support a link between the condition and the Veteran's active service.

The Board denied a higher disability rating for hypertension and a compensable rating for eczema prior to May 19, 2023. The claim for TDIU was remanded.

The Board denied service connection for heart disability, hypertension, right eye cataract, neuropathy in both upper and lower extremities, as well as a TDIU claim. However, SMC based on the need for regular aid and attendance was granted.

The Board remands the claims for service connection for sleep apnea and hypertension to obtain additional medical opinions addressing the relationship between these conditions and the Veteran's service-connected PTSD and lumbar spine degenerative disc disease.

The Board granted a 10 percent rating for impetigo and denied all other claims for increased ratings.

The Board denied the Veteran's claims for increased ratings for hypertension and tinnitus, as the evidence did not support a higher rating under applicable criteria.

The Board granted service connection for systemic lupus erythematosus, alopecia areata, hypertension, sleep apnea, parathyroid cancer, cardiomegaly, bilateral lower extremity peripheral neuropathy, bilateral upper extremity neuropathy, and arthritis of the bilateral feet, ankles, knees, elbows, wrists, and hands.

The Board remands the claims for service connection for PTSD, alcohol abuse, and hypertension due to pre-decisional duty to assist errors.

The appeal for service connection for hypertension and asthma was dismissed due to a timely notice of disagreement not being filed within one year of the rating decision. The claims for diabetes mellitus, type II and glaucoma were remanded for further development.

The Board granted the restoration of a 30 percent rating for migraines due to an improper reduction in the rating, and remanded issues related to service connection for high blood pressure and chronic fatigue syndrome.

The Board remands the claim for service connection for hypertension to obtain an adequate medical opinion regarding its etiology, particularly considering the Veteran's exposure to burn pits.

The Board denied a rating in excess of 10 percent for hypertension and remanded the claim for an evaluation in excess of 20 percent for degenerative arthritis of the thoracic and lumbar spine.

The veteran withdrew all appeals related to the claims for initial disability evaluations and service connection.

The Veteran's claim for service connection for PTSD was granted with an effective date of January 9, 2019. The claims for right lower extremity neurological condition and intracranial hypertension were denied.

The Board granted service connection for bilateral hearing loss and temporomandibular joint (TMJ) disorder, while denying service connection for hypertension, a left arm disability, a left lower extremity neurological disability, a right lower extremity neurological disability, and left knee pain. The Board also granted ratings of 70%, 10%, and 30% for posttraumatic stress disorder with unspecified depressive disorder, dry eye syndrome, and gastroesophageal reflux disease with irritable bowel syndrome, respectively.